title: [Polyoxidonium in complex treatment of diabetic foot syndrome].
authors.forename: T A
authors.initials: TA
authors.lastname: Zelenina
authors.forename: A B
authors.initials: AB
authors.lastname: Zemlianoĭ
authors.forename: T V
authors.initials: TV
authors.lastname: Glazanova
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D017719:Diabetic Foot / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology / Q000601:surgery; D004333:Drug Administration Routes; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000276:immunology; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic; D010879:Piperazines / Q000008:administration & dosage / Q000276:immunology; D011108:Polymers / Q000008:administration & dosage; D012720:Severity of Illness Index; D013514:Surgical Procedures, Operative / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D010879:Piperazines; D011108:Polymers; C540909:azoximer bromide